| Diurnal variations in the expression of core-clock genes correlate with resting muscle properties and predict fluctuations in exercise performance across the day A Basti, M Yalçin, D Herms, J Hesse, O Aboumanify, Y Li, Z Aretz, ... BMJ open sport & exercise medicine 7 (1), e000876, 2021 | 29 | 2021 |
| Solving an MHC allele–specific bias in the reported immunopeptidome MG Klatt, KN Mack, Y Bai, ZEH Aretz, LI Nathan, SS Mun, T Dao, ... JCI insight 5 (19), 2020 | 20 | 2020 |
| Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy A Charles, CM Bourne, T Korontsvit, ZEH Aretz, SS Mun, T Dao, MG Klatt, ... Oncoimmunology 10 (1), 1916243, 2021 | 17 | 2021 |
| A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies MG Klatt, T Dao, Z Yang, J Liu, SS Mun, MM Dacek, H Luo, TJ Gardner, ... Blood, The Journal of the American Society of Hematology 140 (8), 861-874, 2022 | 10 | 2022 |
| Challenges and solutions for therapeutic TCR‐based agents M Malviya, ZEH Aretz, Z Molvi, J Lee, S Pierre, P Wallisch, T Dao, ... Immunological Reviews 320 (1), 58-82, 2023 | 8 | 2023 |
| Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment CM Bourne, SS Mun, T Dao, ZEH Aretz, Z Molvi, RS Gejman, A Daman, ... Blood Advances 6 (14), 4107-4121, 2022 | 8 | 2022 |
| Integrative proteogenomics using ProteomeGenerator2 N Kwok, Z Aretz, S Takao, Z Ser, P Cifani, A Kentsis Journal of proteome research 22 (8), 2750-2764, 2023 | 3 | 2023 |
| An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments MG Klatt, ZEH Aretz, M Curcio, RS Gejman, HF Jones, DA Scheinberg Journal of proteomics 228, 103921, 2020 | 3 | 2020 |
| Unmasking the cryptic immunopeptidome of EZH2 mutated diffuse large B-cell lymphomas through combination drug treatment CM Bourne, SS Mun, T Dao, ZEH Aretz, RS Gejman, A Daman, K Takata, ... bioRxiv, 2021.09. 01.458572, 2021 | | 2021 |
| Poster: CT-080: A Tumor-Agnostic TCR-Mimic CAR-T cell Specific for NDC80 Targets Multiple Hematological Malignancies MG Klatt, T Dao, Z Yang, J Liu, SS Mun, MM Dacek, H Luo, TJ Gardner, ... Clinical Lymphoma Myeloma and Leukemia 21, S257, 2021 | | 2021 |
| CT-080: A Tumor-Agnostic TCR-Mimic CAR-T cell Specific for NDC80 Targets Multiple Hematological Malignancies MG Klatt, T Dao, Z Yang, J Liu, SS Mun, MM Dacek, H Luo, TJ Gardner, ... Clinical Lymphoma Myeloma and Leukemia 21, S447-S448, 2021 | | 2021 |
| Oral Abstract: CT-080: A Tumor-Agnostic TCR-Mimic CAR-T cell Specific for NDC80 Targets Multiple Hematological Malignancies MG Klatt, T Dao, Z Yang, J Liu, SS Mun, MM Dacek, H Luo, TJ Gardner, ... Clinical Lymphoma Myeloma and Leukemia 21, S204, 2021 | | 2021 |
